Skip to main content

News & Press Releases

Featured

ML Strategies Adds Highly Regarded Director of Government Relations in Boston

September 10, 2019

ML Strategies, LLC, the consulting affiliate of the law firm Mintz, today announced that Kaitlyn Sprague has joined the Boston office as Director of Government Relations.

Filter by:

News Thumbnail MLS
In an article published by Law360, Vice President of ML Strategies Christian Fjeld was quoted on how the 2020 election could reshape the communications industry, specifically with regards to leadership on relevant congressional committees and the possibility of reform of Section 230 of the Communications Decency Act.
News Thumbnail MLS
In an article published by Law360, Vice President of ML Strategies Christian Fjeld was quoted on lawmaker efforts to amend Section 230 of the Communications Decency Act.
Press Release Thumbnail MLS
After taking a leave of absence from Mintz to focus on his presidential campaign, former Massachusetts Governor Bill Weld has returned to the firm. He returns to his role as a Member and principal with the firm’s government relations arm, ML Strategies, LLC.
News Thumbnail MLS

Au Pairs Caught Between Work and a Pandemic

April 2, 2020 | The New York Times

In an article published by The New York Times, Senior Vice President, Strategic Communications of ML Strategies Nancy J. Sterling was quoted on behalf of client Au Pair in America, a federally approved organization that helps match au pairs and host families, on resources and support provided to both families and au pairs during the coronavirus pandemic.
News Thumbnail MLS
Vice President of ML Strategies Christian Fjeld was quoted in an article published by Reuters discussing the increase of price gouging due to COVID-19 and its legality.
News Thumbnail MLS
Mintz Member Joanne Hawana, Senior Director of ML Strategies Aaron Josephson, and Mintz Associate Benjamin Zegarelli co-authored an article published in Law360 discussing the latest actions from the U.S. Food and Drug Administration (FDA) in response to COVID-19.

Follow ML Strategies